SmartCella is a biotechnology company developing cell therapy and delivery devices for cardiac diseases.
SmartCella has raised $54.2M in total funding. The most recent round was Private Equity. The last funding was announced in July 2024.
SmartCella's investors include AstraZeneca, SEB (Skandinaviska Enskilda Banken), AMF, Handelsbanken Fonder, Thomas Koch.
SmartCella is headquartered in Tullinge, Sweden.
SmartCella is a biotechnology company developing cell therapy and delivery devices for cardiac diseases.
SmartCella is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SmartCella — Funding & Investors." VCBacked, July 8, 2024, https://www.vcbacked.co/company/smartcella. Accessed August 14, 2026.
VCBacked. (2024). SmartCella — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/smartcella
{{cite web |title=SmartCella — Funding & Investors |url=https://www.vcbacked.co/company/smartcella |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated